Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)

Daorong Wang

Status: Completed

Conditions: Laparoscopic; Anterior Resection for Rectal Cancer; Robotic

Treatments: Procedure: robotic surgery; Procedure: laparoscopic surgery

Study type: Observational

Funder types: Other

Identifiers

NCT06396845

CCI1

Details and patient eligibility

About

This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.

Enrollment: 505 patients

Sex: All

Ages: 55 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

The criteria include: (1) pathology of low rectal cancer (within 10 cm from the anal margin); (2) access to comprehensive pathological and computed tomography (CT) data; (3) completeness of clinical data.

Exclusion criteria

patients with other malignant tumors besides rectal cancer, benign disease surgery, and emergency surgery.

Trial design

505 participants in 2 patient groups

robotic surgery with cci

Treatment:

Procedure: laparoscopic surgery

Procedure: robotic surgery

laparoscopic surgery with cci

Treatment:

Procedure: laparoscopic surgery

Procedure: robotic surgery